Century Therapeutics, Inc. (NASDAQ:IPSC), featuring a year-to-date gain of 114.11% and upside potential of 134.70%, secures a spot on our list of hot biotech stocks under $5 to buy. New preclinical ...

Advancing CNTY-813 as a potential functional cure in Type 1 DiabetesCNTY-813 iPSC-derived islet replacement therapy demonstrates durable in-vivo ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative ...

CNTY-813, Century’s type 1 diabetes iPSC-derived islet therapy with functional-cure potential, remains on track for IND in 4Q 2026; initial ...

Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and ...

BEACHWOOD, Ohio, April 28, 2026 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial launch of TrailBio® ...

The International Society for Stem Cell Research (ISSCR) today announced that registration and abstract submission are open for the ISSCR International Symposium: 20 Years of iPSC Discovery: A ...

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...

In this article, we will list the 5 Best Performing Small Cap Stocks So Far in 2026. Please visit 10 Best Performing Small Cap Stocks So Far in 2026 if you would like to see the extended list and the ...